Tarchomińskie Zakłady Farmaceutyczne PolfaS.A.
Manufacture of pharmaceutical preparations
Overview
Tarchomińskie Zakłady Farmaceutyczne Polfa is a Polish pharmaceutical manufacturer that produces antibiotics, human insulin, dermatological medications, and dietary supplements. The company specializes in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms, operating under cGMP standards. They also provide laboratory services, conducting over 4,000 tests annually, and supply around 25 million packages of prescription and over-the-counter products to medical facilities each year.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 1994-08-01. Active
96 1020 1026 0000 1102 0380 9217- 90 1020 1026 0000 1802 0384 9528
04 1240 1040 1111 0011 1071 8034
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $12.1M$12,109,493 |
Buildings and premises | $25.6M$25,594,174 |
Investment property | $22,602$22,602 |
MSiG notices
70 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| May 26, 2026 | Shareholders' meeting convened | |
| May 6, 2026 | Shareholders' meeting convened | |
| Dec 3, 2025 | Shareholders' meeting convened | |
| Nov 18, 2025 | Shareholders' meeting convened | |
| Aug 13, 2025 | Shareholders' meeting convened |
Public aid
26 public aid cases recorded, with a total value of $4,944,672.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 15, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $37,817$37,817 | Prezydent Miasta Stołecznego Warszawy | |
| Oct 8, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $62,602$62,602 | Prezydent Miasta Stołecznego Warszawy | |
| Jul 4, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $3,014$3,014 | Instytut Nauk Społeczno-Ekonomicznych sp. z o.o. + limited partnership |
Tenders
No recorded participation in tenders.
Trademarks
Tarchomińskie Zakłady Farmaceutyczne Polfa holds 122 active trademarks registered with the Polish Patent Office. 3 applications are pending. 92 marks have expired or were not registered. The first mark was filed in 1966.
| Mark | Protected until | |
|---|---|---|
| DOPSYTAR(word) | Dec 15, 2035 | |
| POLF - FLU f | Oct 15, 2035 | |
| AZONID(word) | Aug 19, 2035 | |
| VELONOX(word) | Jul 15, 2035 | |
| BAXIREN(word) | Jul 15, 2035 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | Integrated permit | Active |
Authorized Representatives
Manner of representation
Joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company. If the management board is a one-person management board, one member of the management board is authorised to make declarations of will on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aflofarm Farmacja Polskasp. z o.o. | $302,019,142.07 | aflofarm.pl | ||
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| BiotonS.A. | $72,911,351.08 | bioton.com | ||
| Wrocławskie Zakłady Zielarskie HerbapolS.A. | $46,537,868.51 | herbapol.pl | ||
| Phytopharm KlękaS.A. | $46,154,888.31 | phytopharm.pl | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $37,103,878.54 | biomed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-02-13 | Share capital change (87,590,000.00 PLN → 184,913,610.00 PLN) | |
| 2001-07-19 | Entered in the register |
FAQ
Last updated: 2026-08-03